SCHEMBL5446259

SCHEMBL5446259

CC(=O)NCc1ccc2cc(O)ccc2c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.55
ALDH1A1 P00352 2/20 0.55
MAPT P10636 2/20 0.55
F13A1 P00488 1/20 0.50
KMT2A Q03164 1/20 0.50
PTPN1 P18031 1/20 0.50
POLA1 P09884 1/20 0.49
HDAC1 Q13547 2/20 0.47
HDAC6 Q9UBN7 1/20 0.47
POLB P06746 1/20 0.46
RAB9A P51151 1/20 0.46
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
HDAC3 O15379 1/20 0.44
HDAC2 Q92769 1/20 0.44
TRPV1 Q8NER1 3/20 0.44
NPSR1 Q6W5P4 1/20 0.43
IDO1 P14902 1/20 0.43
SRC P12931 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8081788 0.84 IDO1 (0.59) KDM4EALDH1A1MAPTKMT2APTPN1
SCHEMBL3720173 0.83 KDM4E (0.70) KDM4EALDH1A1MAPTF13A1MTNR1A
SCHEMBL3612557 0.81 KMT2A (0.66) KDM4EALDH1A1MAPTF13A1KMT2A
SCHEMBL4712377 0.80 SMN1; SMN2 (0.60) KDM4EALDH1A1MAPTRAB9AMTNR1A
SCHEMBL31724652 0.79 CYP1A2 (0.56) KDM4EALDH1A1MAPTKMT2AHDAC1
SCHEMBL5725833 0.79 CYP1A2 (0.56) KDM4EALDH1A1MAPTKMT2AHDAC1
SCHEMBL4672100 0.79 NQO2 (0.52) POLA1HDAC1
SCHEMBL4670284 0.78 ALOX5 (0.46) KDM4EMAPTPTPN1POLA1IDO1
SCHEMBL5441552 0.78 ERCC1 (0.66) KMT2APOLA1HDAC1HDAC6RAB9A
SCHEMBL12133623 0.77 KMT2A (0.76) KDM4EALDH1A1MAPTF13A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007530524-A 2007-11-01 JP claimed
EP-1730103-A1 FORMAMIDE DERIVATIVES USEFUL AS ADRENOCEPTOR Pfizer Limited (GB) 2006-12-13 EP claimed
EP-1708991-A2 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES Pfizer Limited (GB) 2006-10-11 EP claimed
EP-1699497-A1 ANTIMICROBIAL CONTACT LENSES AND METHODS FOR THEIR PRODUCTION Johnson and Johnson Vision Care, Inc. (US) 2006-09-13 EP claimed
WO-2005092840-A1 FORMAMIDE DERIVATIVES USEFUL AS ADRENOCEPTOR PFIZER LIMITED (GB) 2005-10-06 WO claimed
WO-2005080313-A2 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES PFIZER LIMITED (GB) 2005-09-01 WO claimed
WO-2005065731-A1 ANTIMICROBIAL CONTACT LENSES AND METHODS FOR THEIR PRODUCTION JOHNSON & JOHNSON VISION CARE, INC. (US) 2005-07-21 WO claimed
EP-1730103-A1 FORMAMIDE DERIVATIVES USEFUL AS ADRENOCEPTOR Pfizer Limited (GB) 2006-12-13 EP disclosed
WO-2005092840-A1 FORMAMIDE DERIVATIVES USEFUL AS ADRENOCEPTOR PFIZER LIMITED (GB) 2005-10-06 WO disclosed
EP-0775133-B1 NAPHTHALENE AMIDES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION MENARINI LAB (ES) 2001-05-30 EP disclosed
EP-0775133-A1 NAPHTHALENE AMIDES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION LABORATORIOS MENARINI S.A. (ES) 1997-05-28 EP disclosed
WO-1996004267-A1 NAPHTHALENE AMIDES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION LABORATORIOS MENARINI S.A. (ES) 1996-02-15 WO disclosed